These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15709754)

  • 1. Agonist-induced conformational changes in thyrotropin-releasing hormone receptor type I: disulfide cross-linking and molecular modeling approaches.
    Huang W; Osman R; Gershengorn MC
    Biochemistry; 2005 Feb; 44(7):2419-31. PubMed ID: 15709754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Novel mixed mode Monte Carlo/stochastic dynamics simulations of the complex between TRH and TRH receptor.
    Laakkonen LJ; Guarnieri F; Perlman JH; Gershengorn MC; Osman R
    Biochemistry; 1996 Jun; 35(24):7651-63. PubMed ID: 8672466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Experimental analysis and energy minimization of the complex between TRH and TRH receptor.
    Perlman JH; Laakkonen LJ; Guarnieri F; Osman R; Gershengorn MC
    Biochemistry; 1996 Jun; 35(24):7643-50. PubMed ID: 8672465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
    del Camino D; Barros F; Pardo LA; de la Peña P
    Biochemistry; 1997 Mar; 36(11):3308-18. PubMed ID: 9116009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the extracellular loops of the thyrotropin-releasing hormone receptor: evidence for an initial interaction with thyrotropin-releasing hormone.
    Perlman JH; Colson AO; Jain R; Czyzewski B; Cohen LA; Osman R; Gershengorn MC
    Biochemistry; 1997 Dec; 36(50):15670-6. PubMed ID: 9398295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
    Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
    Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linking and disulfide bond formation of introduced cysteine residues suggest a modified model for the tertiary structure of URF13 in the pore-forming oligomers.
    Rhoads DM; Brunner-Neuenschwander B; Levings CS; Siedow JN
    Arch Biochem Biophys; 1998 Jun; 354(1):158-64. PubMed ID: 9633611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the role of transmembrane helix three of the thyrotropin-releasing hormone (TRH) receptor in directly binding TRH.
    Perlman JH; Laakkonen L; Thaw CN; Osman R; Gershengorn MC
    Trans Assoc Am Physicians; 1993; 106():162-7. PubMed ID: 8036739
    [No Abstract]   [Full Text] [Related]  

  • 9. A model of inverse agonist action at thyrotropin-releasing hormone receptor type 1: role of a conserved tryptophan in helix 6.
    Lu X; Huang W; Worthington S; Drabik P; Osman R; Gershengorn MC
    Mol Pharmacol; 2004 Nov; 66(5):1192-200. PubMed ID: 15306657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxyl tail cysteine mutants of the thyrotropin-releasing hormone receptor type 1 exhibit constitutive signaling: role of palmitoylation.
    Du D; Raaka BM; Grimberg H; Lupu-Meiri M; Oron Y; Gershengorn MC
    Mol Pharmacol; 2005 Jul; 68(1):204-9. PubMed ID: 15833733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment.
    Davidson JS; Assefa D; Pawson A; Davies P; Hapgood J; Becker I; Flanagan C; Roeske R; Millar R
    Biochemistry; 1997 Oct; 36(42):12881-9. PubMed ID: 9335546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the structural and functional differences between mouse thyrotropin-releasing hormone receptors 1 and 2.
    Deflorian F; Engel S; Colson AO; Raaka BM; Gershengorn MC; Costanzi S
    Proteins; 2008 May; 71(2):783-94. PubMed ID: 17979196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
    Laakkonen L; Li W; Perlman JH; Guarnieri F; Osman R; Moeller KD; Gershengorn MC
    Mol Pharmacol; 1996 Jun; 49(6):1092-6. PubMed ID: 8649348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed disulfide mapping of residues contributing to the Ca2+ and K+ binding pocket of the NCKX2 Na+/Ca2+-K+ exchanger.
    Kinjo TG; Kang K; Szerencsei RT; Winkfein RJ; Schnetkamp PP
    Biochemistry; 2005 May; 44(21):7787-95. PubMed ID: 15909993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1.
    Kaur N; Monga V; Lu X; Gershengorn MC; Jain R
    Bioorg Med Chem; 2007 Jan; 15(1):433-43. PubMed ID: 17035026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational changes in the cytoplasmic domain of the Escherichia coli aspartate receptor upon adaptive methylation.
    Le Moual H; Quang T; Koshland DE
    Biochemistry; 1998 Oct; 37(42):14852-9. PubMed ID: 9778360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Static and dynamic roles of extracellular loops in G-protein-coupled receptors: a mechanism for sequential binding of thyrotropin-releasing hormone to its receptor.
    Colson AO; Perlman JH; Smolyar A; Gershengorn MC; Osman R
    Biophys J; 1998 Mar; 74(3):1087-100. PubMed ID: 9512011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an in situ disulfide cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor.
    Ward SD; Hamdan FF; Bloodworth LM; Siddiqui NA; Li JH; Wess J
    Biochemistry; 2006 Jan; 45(3):676-85. PubMed ID: 16411743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The computer modelling of human TRH receptor, TRH and TRH-like peptides.
    Bílek R; Stárka L
    Physiol Res; 2005; 54(2):141-50. PubMed ID: 15544424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the structure of the cytoplasmic domain of the aspartate receptor by targeted disulfide cross-linking.
    Chen X; Koshland DE
    Biochemistry; 1997 Sep; 36(39):11858-64. PubMed ID: 9305978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.